DOI QR코드

DOI QR Code

리팜핀 유발성 ANCA 음성 반월상 사구체신염

A Case of Rifampin-Induced Crescentic Glomerulonephritis

  • 이경남 (부산대학교 의학전문대학원 내과학교실) ;
  • 송상헌 (부산대학교 의학전문대학원 내과학교실) ;
  • 이하린 (부산대학교 의학전문대학원 내과학교실) ;
  • 성은영 (부산대학교 의학전문대학원 내과학교실) ;
  • 김일영 (부산대학교 의학전문대학원 내과학교실) ;
  • 이수봉 (부산대학교 의학전문대학원 내과학교실) ;
  • 곽임수 (부산대학교 의학전문대학원 내과학교실)
  • Lee, Kyung-Nam (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Song, Sang-Heon (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Rhee, Ha-Rin (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Seong, Eun-Young (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Kim, Il-Young (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Lee, Soo-Bong (Department of Internal Medicine, Pusan National University School of Medicine) ;
  • Kwak, Ihm-Soo (Department of Internal Medicine, Pusan National University School of Medicine)
  • 발행 : 2012.02.01

초록

특이 병력이 없는 56세 남자가 폐결핵 치료 6주 후 전신 부종과 신손상으로 왔고 신장 조직 검사를 통해 면역음성 반월상 사구체신염으로 진단하였다. 폐결핵을 동반한 상태이므로 세포독성 약물은 사용하지 않았으며 약물 중단과 고용량 메칠프레드니솔론 치료를 통해 신기능 회복을 유도하였고, 리팜핀을 제외한 항결핵 약물로서 안정적으로 폐결핵을 치료할 수 있었다.

A 56-year-old male with pulmonary tuberculosis was admitted to our hospital for evaluation of generalized edema. He began antituberculosis treatment with rifampin, isoniazid, ethambutol, and pyrazinamide. He experienced abnormal increments in weight and serum creatinine after 6 weeks. All serological findings, including anti-neutrophil cytoplasmic antibodies (ANCA), were negative. Rifampin was stopped because it might have caused the increase in creatinine. Renal biopsy was consistent with pauci-immune crescentic glomerulonephritis (CrGN). His renal function was improved by high-dose steroid treatment. Rifampin-induced, ANCA-negative pauci-immune CrGN is very rare; most cases of rifampin-induced acute renal failure are due to acute tubulointerstitial nephritis. We present here a case of rifampin-induced CrGN and pulmonary tuberculosis successfully treated with high-dose steroids and antituberculosis medications, excluding rifampin.

키워드

참고문헌

  1. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003;63:1164-1177. https://doi.org/10.1046/j.1523-1755.2003.00843.x
  2. Lim CS, Jung YC, Lee SG, et al. Rifampin induced rapidly progressive glomerulonephritis. Korean J Nephrol 1998;17: 503-509.
  3. Hirsch DJ, Bia FJ, Kashgarian M, Bia MJ. Rapidly progressive glomerulonephritis during antituberculous therapy. Am J Nephrol 1983;3:7-10. https://doi.org/10.1159/000166679
  4. Murray AN, Cassidy MJ, Templecamp C. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis. Nephron 1987;46:373-376. https://doi.org/10.1159/000184394
  5. Wen YK, Chen ML. Crescentic glomerulonephritis associated with rifampicin in a patient co-infected with tuberculosis and human immunodeficiency virus. Clin Nephrol 2006;65: 284-249. https://doi.org/10.5414/CNP65284
  6. Kohler LJ, Gohara AF, Hamilton RW, Reeves RS. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis. Clin Nephrol 1994;42:263-265.
  7. Ogata H, Kubo M, Tamaki K, Hirakata H, Okuda S, Fujishima M. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis. Nephron 1998;78:319-322. https://doi.org/10.1159/000044942
  8. Moon SC, Park HK, Kwak IS, Shin YW, Shin YK. A case of acute renal failure due to rifampion. Korean J Med 1981; 24:1237-1241.
  9. Yoshioka K, Satake N, Kasamatsu Y, Nakamura Y, Shikata N. Rapidly progressive glomerulonephritis due to rifampicin therapy. Nephron 2002;90:116-118. https://doi.org/10.1159/000046326

피인용 문헌

  1. Drug-Induced Glomerular Disease: Immune-Mediated Injury vol.10, pp.7, 2012, https://doi.org/10.2215/cjn.01910215